According to the random number table, all patients were divided into short-term treatment group, long-term treatment group and non-intervention stroke control group according to the proportion of (1:1:1) epilepsy disease modifier idebenone. Patients in the short-term treatment group will take idebenone for a total course of 14 days (acute period) after stroke, and patients in the long-term treatment group will take idebenone for a total course of 3 months after stroke.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The proportion of patients with epilepsy after stroke
Timeframe: At the time of enrollment
The proportion of patients with epilepsy after stroke
Timeframe: 24 weeks after enrollment
The proportion of patients with epilepsy after stroke
Timeframe: 48 weeks after enrollment